Evidence map›Paper›PMID 37804448›Full record

ArticleEuropean journal of nutrition2024

Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries.

Tammy Y N Tong, Robert Clarke, Julie A Schmidt, Inge Huybrechts, Urwah Noor, Nita G Forouhi, Fumiaki Imamura, Ruth C Travis, Elisabete Weiderpass, Krasimira Aleksandrova and 33 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 20 institutions in 10 countries.

Tammy Y N TongCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3 7LF, UK. tammy.tong@ndph.ox.ac.uk.ORCID http://orcid.org/0000-0002-0284-8959
Robert ClarkeClinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Julie A SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3 7LF, UK.
Inge HuybrechtsNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France.
Urwah NoorCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3 7LF, UK.
Nita G ForouhiMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Fumiaki ImamuraMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3 7LF, UK.
Elisabete WeiderpassInternational Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France.
Krasimira AleksandrovaDepartment Epidemiological Methods and Etiological Research, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Yvonne T van der SchouwJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Kim OvervadDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Cecilie KyrøDanish Cancer Society Research Center, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Catarina SchibornDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Ana-Lucia Mayen-ChaconNutrition and Metabolism Branch, International Agency for Research on Cancer (IARC), World Health Organization (WHO), Lyon, France.
Giovanna MasalaInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.
Maria Santucci de MagistrisAzienda Ospedaliera Universitaria Federico II, Naples, Italy.
Rosario TuminoHyblean Association for Epidemiological Research AIRE-ONLUS, Ragusa, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.
Jolanda M A BoerNational Institute for Public Health and the Environment, Bilthoven, The Netherlands.
W M Monique VerschurenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Magritt BrustadDepartment of Community Medicine, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.
Therese Haugdahl NøstDepartment of Community Medicine, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.
Marta Crous-BouUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Dafina PetrovaEscuela Andaluza de Salud Pública (EASP), Granada, Spain.
Pilar AmianoCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, C. de Melchor Fernández Almagro, Madrid, Spain.
José María HuertaCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, C. de Melchor Fernández Almagro, Madrid, Spain.
Conchi Moreno-IribasCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, C. de Melchor Fernández Almagro, Madrid, Spain.
Gunnar EngströmDepartment of Clinical Science in Malmö, Lund University, Clinical Research Center, Malmö, Sweden.
Olle MelanderDepartment of Clinical Science in Malmö, Lund University, Clinical Research Center, Malmö, Sweden.
Kristina JohanssonDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Kristina LindvallDepartment of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
Elom K AglagoDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Adam S ButterworthBritish Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
John DaneshBritish Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Timothy J KeyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3 7LF, UK.
University of Oxford · GBUniversity of Cambridge · GBCentre international de recherche sur le cancer · FRInstituto de Salud Carlos III · ESAarhus University · DKDanish Cancer Society · DKGerman Cancer Research Center · DEImperial College London · GBLund University · SEUmeå University · SEUtrecht University · NLAarhus University Hospital · DKAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITBasque Government · ESDeutsches Diabetes-Zentrum e.V. · DEFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITHarvard University · USItalian Association for Cancer Research · ITNational Institute for Public Health and the Environment · NL

Funding

British Heart Foundation RG/13/13/30194Cancer Research UK 29017Cancer Research UK 570/A16491Cancer Research UK C8221/A19170Medical Research Council G0800270Medical Research Council G1000143Medical Research Council MC_UU_00006/3Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/5Medical Research Council MR/L003120/1Medical Research Council MR/M012190/1Wellcome TrustWellcome Trust Livestock EnvironmentWellcome Trust Our Planet Our HealthWellcome Trust People 205212/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

purposePreviously reported associations of protein-rich foods with stroke subtypes have prompted interest in the assessment of individual amino acids. We examined the associations of dietary amino acids with risks of ischaemic and haemorrhagic stroke in the EPIC study.

methodsWe analysed data from 356,142 participants from seven European countries. Dietary intakes of 19 individual amino acids were assessed using validated country-specific dietary questionnaires, calibrated using additional 24-h dietary recalls. Multivariable-adjusted Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of ischaemic and haemorrhagic stroke in relation to the intake of each amino acid. The role of blood pressure as a potential mechanism was assessed in 267,642 (75%) participants.

resultsAfter a median follow-up of 12.9 years, 4295 participants had an ischaemic stroke and 1375 participants had a haemorrhagic stroke. After correction for multiple testing, a higher intake of proline (as a percent of total protein) was associated with a 12% lower risk of ischaemic stroke (HR per 1 SD higher intake 0.88; 95% CI 0.82, 0.94). The association persisted after mutual adjustment for all other amino acids, systolic and diastolic blood pressure. The inverse associations of isoleucine, leucine, valine, phenylalanine, threonine, tryptophan, glutamic acid, serine and tyrosine with ischaemic stroke were each attenuated with adjustment for proline intake. For haemorrhagic stroke, no statistically significant associations were observed in the continuous analyses after correcting for multiple testing.

conclusionHigher proline intake may be associated with a lower risk of ischaemic stroke, independent of other dietary amino acids and blood pressure.

Indexed as

Brain IschemiaHemorrhagic StrokeIschemic StrokeStrokeAmino AcidsHumansProlineProspective StudiesRisk FactorsAmino AcidsProlineAmino acidsDietary proteinHaemorrhagic strokeIschaemic strokeNutritional epidemiologyProspective cohort

Identifiers

PMID37804448
PMCPMC10799144
OpenAlexW4387426405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.